
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.71 | -21.0059171598 | 3.38 | 3.5 | 2.45 | 12089 | 2.74358966 | CS |
4 | -1.23 | -31.5384615385 | 3.9 | 4.1204 | 2.45 | 6897 | 3.16648325 | CS |
12 | -1.53 | -36.4285714286 | 4.2 | 4.34 | 2.45 | 6001 | 3.72655933 | CS |
26 | -1.6 | -37.4707259953 | 4.27 | 4.73 | 2.45 | 14617 | 3.99884919 | CS |
52 | -1.42 | -34.7188264059 | 4.09 | 5.2 | 2.45 | 12654 | 3.96893347 | CS |
156 | -8.13 | -75.2777777778 | 10.8 | 12.5 | 2.40101 | 38662 | 6.29382242 | CS |
260 | -5.03 | -65.3246753247 | 7.7 | 56.8 | 2.40101 | 668228 | 27.54764664 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관